Buy Tesamorelin 2mg

£20.99

  • HPLC Purity: ≥98%
  • Quantity: 2mg
  • Peptide Length: 44 amino acids
  • Appearance: Lyophilised powder
  • Type: Synthetic GHRH analogue
  • Research Focus: GHRH receptor signalling, GH secretion, cAMP/PKA pathways and IGF-1 signalling
  • Storage: Store lyophilised material at −20°C; follow validated laboratory protocols after reconstitution

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) investigated in in-vitro testing and preclinical research for its interaction with the GHRH receptor and somatotropic signalling pathways. It provides a research model for qualified laboratory experimentation involving GH pulsatility, IGF-1 signalling and adipose cell culture studies.

Buy More, Save More!

Buy More, Save More!
Quantity Discount Price You save
3, 4 3% off £20.36 £0.63
5, 9 5% off £19.94 £1.05
10, 14 10% off £18.89 £2.10
15, 24 15% off £17.84 £3.15
25+ Best value 20% off £16.79 £4.20
Category:
Description

Buy Tesamorelin 2mg – Loti Labs UK

1. Compound Overview & Technical Specifications

Tesamorelin 2mg is a synthetic analogue of growth hormone-releasing hormone (GHRH), designed to reproduce the signalling characteristics of endogenous GHRH while incorporating an N-terminal modification that influences peptide stability.

The peptide is extensively studied as an experimental tool for investigating the somatotropic axis, including GHRH receptor activation, intracellular cAMP signalling, growth hormone secretion and downstream IGF-1 pathways.

Loti Labs UK supplies Tesamorelin 2mg as a lyophilised research-grade powder intended exclusively for qualified laboratory experimentation.

Quick Research Specifications

  • Product: Tesamorelin 2mg
  • HPLC Purity: ≥98%
  • Quantity: 2mg
  • Peptide Length: 44 amino acids
  • Type: Synthetic GHRH analogue
  • Appearance: Lyophilised powder
  • Research Area: Somatotropic axis and peptide-receptor signalling
  • Key Target: Growth hormone-releasing hormone receptor (GHRHR)
  • Key Pathways: cAMP, protein kinase A (PKA), GH and IGF-1 signalling

Structural Characteristics

Tesamorelin 2mg is based on the 44-amino-acid GHRH sequence and incorporates an N-terminal trans-3-hexenoic acid modification.

This modification has been investigated for its influence on resistance to enzymatic degradation compared with native GHRH. The resulting research profile makes tesamorelin useful for controlled investigations into sustained GHRH-receptor signalling.

Storage & Laboratory Handling

  • Store the lyophilised material at −20°C.
  • Reconstitution should be performed using an appropriate sterile laboratory diluent according to the validated experimental protocol.
  • Minimise repeated freeze-thaw cycles after reconstitution.
  • Reconstituted material should be handled and stored according to established laboratory peptide-storage procedures.
  • Researchers should independently verify analytical identity and purity where required by the experimental protocol.

2. Mechanism of Action & Research Context

GHRH Receptor Activation

Tesamorelin acts as a GHRH analogue and is investigated for its interaction with the growth hormone-releasing hormone receptor (GHRHR).

GHRHR is expressed on somatotroph cells within the anterior pituitary. Activation of this receptor provides an experimental model for studying signalling mechanisms associated with growth hormone secretion.

cAMP and PKA Signalling

Following GHRHR activation, research models examine downstream intracellular signalling involving adenylyl cyclase, cyclic AMP (cAMP) and protein kinase A (PKA).

This signalling cascade provides a useful framework for investigating how extracellular peptide-receptor interactions translate into intracellular responses and subsequent GH-related signalling.

Growth Hormone and IGF-1 Research

One of the principal research applications of tesamorelin is investigation of the GH/IGF-1 axis.

Experimental models can examine the relationship between GHRH-receptor activation, growth hormone release and downstream insulin-like growth factor-1 (IGF-1) signalling.

This makes tesamorelin relevant to qualified laboratory research investigating endocrine signalling, peptide-receptor interactions and somatotropic-axis regulation.

Adipose Cell Culture Research

The GH/IGF-1 axis has an established relationship with adipose biology, making tesamorelin relevant to adipose cell culture studies investigating signalling pathways associated with adipocyte biology and lipid-related cellular processes.

Such research should be performed using controlled experimental systems and appropriately validated laboratory protocols.

Peptide Stability Research

The N-terminal modification incorporated into tesamorelin has been investigated for its ability to alter peptide stability compared with native GHRH.

This characteristic provides researchers with an experimental model for comparing peptide stability, receptor activation and duration of signalling between modified and unmodified GHRH-related compounds.


Comparative Research Context

Tesamorelin vs Native GHRH

Tesamorelin is designed around the 44-amino-acid GHRH sequence while incorporating an N-terminal modification.

This provides a useful experimental comparison when investigating how structural modification affects peptide stability, receptor interaction and downstream signalling.

Tesamorelin vs Direct GH Secretagogues

Tesamorelin operates through the GHRH receptor pathway, making it mechanistically distinct from research compounds that act through growth-hormone secretagogue receptors.

This distinction can be useful when designing laboratory experiments intended to separate GHRH-mediated signalling from other GH-secretagogue mechanisms.

Tesamorelin vs CJC-1295

Tesamorelin and CJC-1295 are both investigated as GHRH-related research compounds, but their structural characteristics and pharmacological profiles differ.

Tesamorelin provides a useful model for investigating GHRH-receptor signalling and GH pulsatility, while different CJC-1295 configurations can be used in comparative research examining peptide stability and signalling duration.

Tesamorelin vs Ipamorelin

Ipamorelin is investigated as a growth-hormone secretagogue acting through a different receptor pathway from GHRH analogues.

Comparative laboratory research can therefore examine distinct mechanisms contributing to GH-related signalling and investigate interactions between separate receptor systems under controlled experimental conditions.


3. Literature & Citation Index

  • Falutz J, et al. Effects of tesamorelin (TH9507), a growth hormone–releasing factor analog, in HIV-infected patients with excess abdominal fat. Journal of Acquired Immune Deficiency Syndromes. 2007;45(3):286–297.
  • Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinology and Metabolism Clinics of North America. 2012;41(2):425–443.
  • Sigalos JT, Pastuszak AW. The safety and efficacy of growth hormone secretagogues. Sexual Medicine Reviews. 2018;6(1):45–53.
  • Bhagra S, et al. Growth hormone therapy in adults: physiological and clinical considerations. Postgraduate Medical Journal. 2011;87(1028):434–443.

4. Laboratory Terms & Compliance

Laboratory Research Use Only.

Tesamorelin 2mg is supplied exclusively as a research-grade compound for qualified laboratory experimentation, in-vitro testing and preclinical research. It may be investigated in controlled experimental systems involving GHRH receptor signalling, somatotropic-axis research, IGF-1 pathways and adipose cell culture studies.

This product is not intended for human or veterinary consumption or administration and is not supplied as a medicine, dietary supplement, food product or cosmetic ingredient. No claims are made regarding the diagnosis, treatment, prevention or cure of any disease or medical condition.

Researchers and laboratory professionals are responsible for ensuring that all handling, storage, experimentation and disposal procedures comply with applicable UK and European legislation, institutional requirements and laboratory safety protocols.

This product is sold for research/laboratory usage only. No other uses are permitted.

Additional information
Purity

≥99%

Form

Lyophilised vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy Tesamorelin 2mg”